5[1]Graham MV, Purdy JA, Emami B, et al. Clinical dosevolume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC) [J].Int J Radiat Oncol Biol Phys, 1999,45:323-329.
6[2]Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients [J].Int J Radiat Oncol Biol Phys, 1998,42:1-9.
7[3]Hernando ML, Marks LB, Bentel GC, et al. Radiation induced pulmonary toxicity:A dose-volume histogram analysis in 201 patients with lung cancer [J].Int J Radiat Oncol Biol Phys, 2001,51:650-659.
9[5]Kwa SL, Theuws CM, Wagenaar A, et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis [J].Radiother & Oncol. 1998,48: 61-69.
10[6]Nutting CM, Bedford JL,Cosgrove VP, et al, A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy [J].Radiother & Oncol,2001 ,61:157-163.
7Beriwal S, HeronDE, KimH, et al. Intensity modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetrie study with early clinical outcome. Radiat Oncol Biol Phys. 2006, Aprl ; 64 ( 5 ) : 1395,1400.
8Jhlngran A. Potential advantages of intensity - modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol. 2006 Jul ; 16 (3) : 144 - 151.
9Walter B,Jones MD. Newapproaches to high risk cervical carcinoma. Cancer, 1993,71 ( 1 ) : 1452.
10Gerszten K, Selva raj RN, Kelley J, et al. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol,2005,12, ;99 ( 3 ) :640 - 644.
